The frequent presence of tumor hypoxia, HIF1α, and HIF2α in solid tumors, including breast cancer, suggests that these tumor areas may possess inherent antiestrogen resistance that can withstand therapy and contribute to treatment failure. Here, HIF1A is linked to breast carcinoma.